Pure Global AI
NCT06291233Not yet recruiting

A Hybrid Effectiveness-Implementation Randomized Clinical Trial (RCT) of Virtual Interview Training for Autistic Transition-Age Youth

A Hybrid Effectiveness-Implementation RCT of Virtual Interview Training for Autistic Transition-Age Youth
University of MichiganClinicalTrials.govbehavioral
Study focus
Drug/Device/Intervention
Virtual Interview Training (VIT)
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Michigan
Location
San Diego,Ann Arbor,Detroit,Lincoln Park, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Mar 01, 2026
Enrollment
200 participants
Primary outcome

Competitive Employment based on self-report employment surveys,Change in Job Interview Skills from Mock Interview Rating Scale (MIRS),Change in Job Interview Skills from Measure of Job Interview Skills (MOJO-iSkills),Time to Employment,Vocational Index Score,Vocational Index Score

Summary

The purpose of the study is to see if an internet job interview training program can help
 people that have autism improve interview skills and access to jobs.
 
 Participants will be randomized to use Virtual Interview Training (VIT) or continue services
 as usual (active control group).

ICD-10 classifications
Childhood autismAtypical autismAsperger syndromeNeurotic disorder, unspecifiedMental and behavioural disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06291233
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06291233 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Not yet recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.